Last updated on November 2017

A Phase 3 Randomized, Double-Blind, Active-Controlled, Multicenter Study of the Long-Term Safety and Efficacy of Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee


Brief description of study

A Phase 3 Randomized, Double-Blind, Active-Controlled, Multicenter Study of the Long-Term Safety and Efficacy of Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee

Detailed Study Description

The purpose of this research study is to evaluate the long-term safety and effectiveness of an investigational medication in subjects with osteoarthritis of the hip or knee.

Clinical Study Identifier: TX11215

Contact Investigators or Research Sites near you

Start Over

Jay Dobson

Northwest Clinical Research Center
Bellevue, WA USA